FDA Clears Wearable for Remote Cardiopulmonary Monitoring
The non-invasive wearable device captures cardiopulmonary measurements for chronic disease management such as heart failure.
Read More
Author: Alyx Arnett
FDA Greenlights Drug-Coated Balloon for In-Stent Restenosis
The FDA approves Boston Scientific Corporation’s AGENT Drug-Coated Balloon for treating coronary in-stent restenosis, marking the first drug-coated coronary balloon approval in the United States.
Read More
Smoking Cannabis Ups Heart Attack and Stroke Risk
Daily use was associated with a 25% increased likelihood of heart attack and a 42% increased likelihood of stroke.
Read More
Daylight Saving Time’s Impact on Heart Health Deemed Insignificant
A recent Mayo Clinic study examining the effects of daylight saving time on heart health suggests that the impact is likely minimal.
Read More
Drug for Male Pattern Baldness Surprisingly Lowers Cholesterol
The drug, which also treats enlarged prostate, may also lower cholesterol and cut the overall risk of heart disease.
Read More